Search

everythinglearnresearchcommunity

for

Search:↓

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Finasteride effectively treats central serous chorioretinopathy.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

More research is needed to confirm the long-term effects of oral drugs for chronic central serous chorioretinopathy.

The woman was diagnosed with Vogt–Koyanagi–Harada disease and successfully treated with medication, restoring her vision and stopping headaches.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Using 2% minoxidil for baldness treatment might cause vision distortion due to fluid build-up under the retina.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Taking Propecia might lead to the development of cataracts.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Finasteride, often used for hair loss, can potentially cause cataracts.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Hair follicle stem cells help skin heal and grow during stretching.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

People with polycystic ovary syndrome often have low levels of vitamin D.

A woman lost vision in one eye after a forehead injection, but prompt treatment led to partial vision recovery.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Using Minoxidil for hair loss might cause eye problems, but it's not certain.

Regenerated fully functional hair follicles using stem cells, with potential for hair regrowth therapy.

Hair follicle regeneration needs special conditions and young cells.

Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.

Advanced human skin models improve drug development and could replace animal testing.

Scientists successfully created and transplanted bioengineered hair follicles that function like natural ones, suggesting a new treatment for hair loss.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.